A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome - Mooney, C J; Nagaiah, G; Fu, P (Thyroid, 2009)
et al.